Francia Silvia De

Publications10
h-index1
Citations4
Highly Influential Citations0
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.
  • Publications
  • Influence
Do mitotane levels impact on the outcome of patients treated adjuvantly following radical resection of adrenocortical cancer (ACC)
  • 3
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib pharmacokinetics in chronic myeloid leukaemia patients
Imatinib is the gold standard for the treatment of chronic myeloid leukaemia (CML) [1]. Several studies revealed correlation between imatinib trough plasma levels and clinical response, suggesting… Expand
RRM1 Gene expression affects metabolization and activity of mitotane in adrenocortical cancer cell lines.
Assessment of the hypothalamic pituitary adrenal axis in patients receiving adjuvant mitotane treatment after radical resection of adrenocortical carcinoma
Germline CYP2W1*6 polymorphism is a new predictive marker of sensitivity to mitotane treatment in advanced adrenocortical carcinoma: a multicenter European study
Determinanti farmacogenetici della farmacocinetica del mitotane: studio condotto su pazienti affetti da carcinoma corticosurrenalico
New hplc-mass spectrometry method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib, and nilotinib
EVALUATION OF NAUSEA AND VOMITING IN ONCOLOGYPATIENTS TREATED WITH CHEMOTHERAPY: A RETROSPECTIVESTUDY
Clinical and biochemical effects of adjuvant mitotane treatment in patients with adrenocortical cancer (ACC)
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients
  • 1